<DOC>
	<DOCNO>NCT01583218</DOCNO>
	<brief_summary>The purpose study evaluate whether extend prophylaxis oral betrixaban prevent blood clot leg lung sometime occur patient hospitalize acute medical illness compare result standard care enoxaparin . The safety betrixaban also study .</brief_summary>
	<brief_title>Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study ( The APEX Study )</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>men nonpregnant , nonbreastfeeding woman anticipate severely immobilize least 24 hour randomization hospitalize one follow congestive heart failure acute respiratory failure , acute infection without septic shock , acute rheumatic disorder acute ischemic stroke lower extremity hemiparesis hemi paralysis condition require prolonged anticoagulation antiplatelets active bleeding high risk bleed contraindication anticoagulant therapy general condition subject suitable participate study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Phase III</keyword>
</DOC>